Facebook
Twitter
LinkedIn
ForwardAnalgesic Compounding – Laboratory Training
As it stands today, first-line treatments for pain management are often associated with adverse systemic effects, including gastrointestinal erosions, constipation, central nervous system depression, addiction, and tolerance. Moreover, many currently available commercial analgesics are limited in therapeutic efficacy, rendering many pain symptoms left untreated or inadequately managed. With compounded topical creams and gels, patients are better able to target the site of action through local application to affected regions, limiting systemic reactions and in many cases, improving therapeutic outcome. In addition, compounders can develop low-dose multi-drug formulations that reach multiple nociceptive pathways, further optimizing targeted effect and ultimately therapeutic payoff.
The objective of this laboratory training is to expose pharmacists and technicians to the hands-on experience of compounding dosage forms common to the niche market of analgesic therapy, notably creams, gels, and pastes. Participants will learn how to optimize the efficiency and quality of their compounding process by practicing novel compounding techniques and implementing innovative technologies and equipment.
Featured formulas:
- Clonidine HCl 0.16%, Gabapentin 6%, Ketamine† HCl 5.75 % Topical Cream
- Diclofenac Sodium 5% Topical Gel
- Capsaicin 0.025%, Lidocaine 6%, Tetracaine 4% Dental Paste
Note: Formulas are subject to change.
†Controlled substances will be replaced by non-controlled substances.
Duration: 4 hours
COPYRIGHT:
The live activity workbook is copyright © 2017 LP3 Network.
CANCELLATION AND REFUND POLICY:
In the event that LP3 Network cancels a course, LP3 Network's sole liability shall be course repayment. In no event shall LP3 Network be responsible for any costs related to travel and/or accommodation. A written request must be sent to LP3 Network Inc. requesting ‘Cancellation without Transfer’ to an alternate live activity event date. If cancellation occurs at greater than or equal to 31 days from live activity event date, then registrant will receive a 75% refund; 15-30 days a 50% refund; and less than or equal to 14 days no refund. There are no refunds, returns, or transfer requests upon purchase of a home study, digital work book, webinar, and eLearning modules. LP3 NETWORK INC. shall be excused from any delay caused by reason of any occurrence or contingency beyond its reasonable control (a “Force Majeure”), including but not limited to, acts of God, hurricane, earthquake, labour disputes, strikes, riots, war, and governmental requirements. The obligation to pay money to LP3 NETWORK INC. in a timely manner is absolute and shall not be subject to this Force Majeure provision. In such event, LP3 NETWORK INC. will not issue any refunds, only transfer to an alternate live activity event date.
TRANSFER POLICY:
The transfer policy is only in effect if requested greater than or equal to 14 days prior to the original live activity date. Failure to submit the “Transfer Request” at least 14 days prior to the original live activity date will default to the “Cancellation and Refund Policy”. The transfer policy can only be applied one (1) time. Transfer to a new live activity date must be within the current calendar year. Failure to attend the new live activity will result in no refund and will no longer be transferable. Confirmation of the new activity date is subject to approval by LP3 Network based on the number of available seats within the selected live activity. There are no refunds, returns, or transfers upon purchase of the home study.
